AI Scribes Moving From Notes to Payments

The real prize in AI scribing is not the note, it is control of the clinical workflow that determines what gets documented, coded, and paid. Once a scribe reliably captures the visit conversation, it can pull chart context before the visit, draft the note during the visit, suggest diagnoses and billing codes after the visit, and eventually feed the claim and payment workflow. That is why note capture is becoming the entry product rather than the whole business.

• Freed is taking the lightest entry point into that stack. It sells a $99 per month self serve scribe to individual clinicians and small practices, then adds higher value products like AI precharting and coding on top of the same visit data. That model helped it reach an estimated $19M ARR and 17,000 clinicians by March 2025.
  1 sacra 4 sacra
• Enterprise players are already showing what expansion looks like. Abridge moved from documentation into billing ready notes and revenue cycle workflows, with products tied to diagnoses, orders, HCC capture, coding, and reimbursement. Ambience is pushing the same direction with real time ICD-10 and CPT support built into documentation.
  2 sacra 5 abridge 6 ambiencehealthcare
• The limiting factor is not transcription accuracy alone, it is integration depth. In healthcare, a scribe only becomes truly valuable when it can write back into the EHR, fill discrete fields, place orders, support coding, and fit the compliance and business agreement requirements that come with larger health systems.
  3 sacra 2 sacra

From here, the category keeps climbing the value chain. Bottom up products like Freed will keep using the note as a wedge into coding and payments for small practices, while enterprise vendors push deeper into inpatient and revenue cycle workflows. The winners will be the companies that turn a recorded conversation into an end to end chart, code, and cash workflow inside the EHR.